{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T14:43:20Z","timestamp":1774709000609,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Interv and Ther"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s12928-024-01001-9","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T18:01:41Z","timestamp":1713376901000},"page":"293-301","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Retrospective analysis on diameters of drug-coated balloons and predilatation balloons in infra-inguinal endovascular treatment (RABBIT study)"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0214-8469","authenticated-orcid":false,"given":"Yo","family":"Iwata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuyoshi","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Tobita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Horie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Nakama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Fukuzawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"key":"1001_CR1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","volume":"131","author":"G Tepe","year":"2015","unstructured":"Tepe G, Laird J, Schneider P, Brodmann M, Krishnan P, Micari A, et al. Drug-coated balloon versus standard percutaneous angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease. Circulation. 2015;131:495\u2013502.","journal-title":"Circulation"},{"key":"1001_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jcin.2013.05.022","volume":"7","author":"D Scheinert","year":"2014","unstructured":"Scheinert D, Duda S, Zeller T, Krankenberg H, Ricke J, Bosiers M, et al. The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization. JACC Cardiovasc Interv. 2014;7:10\u20139.","journal-title":"JACC Cardiovasc Interv"},{"key":"1001_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1177\/15266028211058683","volume":"29","author":"K Horie","year":"2022","unstructured":"Horie K, Tanaka A, Taguri M, Inoue N. Impact of baseline and postprocedural intravascular ultrasound findings on 1- year primary patency after drug-coated balloon treatment of femoropopliteal lesions. J Endovasc Ther. 2022;29:66\u201375.","journal-title":"J Endovasc Ther"},{"key":"1001_CR4","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.5551\/jat.63886","volume":"30","author":"K Horie","year":"2023","unstructured":"Horie K, Takahara M, Nakama T, Tanaka A, Tobita K, Hayakawa N, et al. Impact of postoperative lumen gain on the reduction of restenosis risk after endovascular treatment using drug-coated balloon for femoropopliteal lesions assessed by intravascular ultrasound. J Atheroscler Thromb. 2023;30:1142\u201351.","journal-title":"J Atheroscler Thromb"},{"key":"1001_CR5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/15266028221081082","volume":"30","author":"N Kurata","year":"2023","unstructured":"Kurata N, Iida O, Takahara M, Asai M, Masuda M, Okamoto S, et al. Clinical impact of the size of drug-coated balloon therapy on restenosis rate in femoropopliteal lesions. J Endovasc Ther. 2023;30:269\u201380.","journal-title":"J Endovasc Ther"},{"key":"1001_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1177\/1526602817698634","volume":"24","author":"M Fujihara","year":"2017","unstructured":"Fujihara M, Takahara M, Sasaki S, Nanto K, Utsunomiya M, Iida O, et al. Angiographic dissection patterns and patency outcomes after balloon angioplasty for superficial femoral artery disease. J Endovasc Ther. 2017;24:367\u201375.","journal-title":"J Endovasc Ther"},{"key":"1001_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1177\/1526602818756610","volume":"25","author":"M Tan","year":"2018","unstructured":"Tan M, Urasawa K, Koshida R, Haraguchi T, Kitani S, Igarashi M, et al. Comparison of angiographic dissection patterns caused by long or short balloons during balloon angioplasty for chronic femoropoliteal occlusions. J Endovasc Ther. 2018;25:192\u2013200.","journal-title":"J Endovasc Ther"},{"key":"1001_CR8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1177\/1526602819887954","volume":"27","author":"E Karashima","year":"2020","unstructured":"Karashima E, Yoda S, Yasuda S, Kajiyama S, Ito H, Kaneko T. Usefulness of the \u201cnon-slip element\u201d percutaneous transluminal angioplasty balloon in the treatment of femoropopliteal arterial lesions. J Endovasc Ther. 2020;27:102\u20138.","journal-title":"J Endovasc Ther"},{"key":"1001_CR9","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1177\/1526602818799733","volume":"25","author":"K Horie","year":"2018","unstructured":"Horie K, Tanaka A, Taguri M, Kato S, Inoue N. Impact of prolonged inflation times during plain old balloon angioplasty on angiographic dissection in femoropopliteal lesions. J Endovasc Ther. 2018;25:683\u201391.","journal-title":"J Endovasc Ther"},{"key":"1001_CR10","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1253\/circrep.CR-20-0095","volume":"2","author":"M Sugihara","year":"2020","unstructured":"Sugihara M, Mine K, Futami M, Kato Y, Arimura T, Yano M, et al. Efficacy of super slow inflation as lesion preparation for drug-coated balloons in femoropopliteal lesions. Circ Rep. 2020;2:682\u201390.","journal-title":"Circ Rep"},{"key":"1001_CR11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s12928-022-00875-x","volume":"37","author":"M Fujihara","year":"2022","unstructured":"Fujihara M, Kurata N, Yazu Y, Mori S, Tomoi Y, Horie K, et al. Clinical expert consensus document on standards for lower extremity artery disease of imaging modality from the Japan Endovascular Treatment Conference. Cardiovasc Interv Ther. 2022;37:597\u2013612.","journal-title":"Cardiovasc Interv Ther"},{"key":"1001_CR12","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.025677","volume":"12","author":"Y Soga","year":"2023","unstructured":"Soga Y, Takahara M, Iida O, Tomoi Y, Kawasaki D, Tanaka A, et al. Vessel patency and associated factors of drug-coated balloon for femoropopliteal lesion. J Am Heart Assoc. 2023;12: e025677.","journal-title":"J Am Heart Assoc"},{"key":"1001_CR13","unstructured":"Nakama T, Takahara M, Iwata Y, Suzuki K, Tobita K, Hayakawa N et al. Low-dose vs high-dose drug-coated balloon for symptomatic femoropopliteal artery disease. JACC Cardiovasc Interv 2023: 11: S1936\u20138798(23)01205\u20130."}],"container-title":["Cardiovascular Intervention and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-024-01001-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12928-024-01001-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-024-01001-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T17:09:47Z","timestamp":1718039387000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12928-024-01001-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["1001"],"URL":"https:\/\/doi.org\/10.1007\/s12928-024-01001-9","relation":{},"ISSN":["1868-4300","1868-4297"],"issn-type":[{"value":"1868-4300","type":"print"},{"value":"1868-4297","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,17]]},"assertion":[{"value":"21 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Tatsuya Nakama is a consultant for BD, Boston Scientific, Century Medical, Cook Medical, Cordis Cardinal Health, Kaneka Medix, NIPRO, and Orbus Neich. The remaining authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the local ethics committees at all participating centers, and the study was performed in accordance with the Declaration of Helsinki. The requirement for informed consent was waived considering the retrospective study design, where existing medical records were used.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval, consent to participate, and publish"}}]}}